Literature DB >> 25208456

Platelet activation increases in patients undergoing vascular surgery.

Gabriel S Schneider1, Caron B Rockman2, Jeffrey S Berger3.   

Abstract

BACKGROUND: Platelets are a major contributor to atherothrombosis and may contribute to the heightened risk of perioperative cardiovascular events. We sought to examine changes in platelet activity in subjects undergoing vascular surgery.
METHODS: Platelet activity in 18 patients (median age 74, 45% female) undergoing non-emergent open vascular surgery was assessed by light transmission aggregometry in response to saline, epinephrine and adenosine-5 diphosphate (ADP), and by flow cytometric analysis of monocyte-platelet aggregation (MPA). Platelet activity was assessed preoperatively (T1), 1-hour into the operation (T2), 1-hour (T3), 24-hours (T4) and 48-hours post-operatively (T5). Data were compared using the Wilcoxon Signed Ranks Test. Continuous variables are summarized as medians and (interquartile, IQR) ranges.
RESULTS: Spontaneous platelet aggregation increased transiently during the surgical period (T1-5.8% [2.4, 10.8], T2-13.5% [9.3, 26.5], T3-7.5% [3.3, 17], T4-10.0% [7.3, 16.3], T5-7.25% [4.5, 29.9], P=0.002). Similar trends in perioperative platelet activity were noted for platelet aggregation in response to epinephrine (P=0.035) and ADP (P=0.036). Using flow cytometry, we found an increase in MPA during the perioperative period (P=0.047), which was most significant between T1 and T3 (P=0.005).
CONCLUSIONS: Platelet activity increases significantly during and following open vascular surgery. This data may help explain the pathophysiology of increased thrombotic risk during the perioperative period of vascular surgery.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25208456      PMCID: PMC4533998          DOI: 10.1016/j.thromres.2014.08.009

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  20 in total

1.  Perioperative activation of hemostasis in vascular surgery patients.

Authors:  C M Samama; D Thiry; I Elalamy; M Diaby; J J Guillosson; E Kieffer; P Coriat
Journal:  Anesthesiology       Date:  2001-01       Impact factor: 7.892

Review 2.  Acute coronary syndromes: pathophysiology and preventive priorities.

Authors:  J J Badimon; A Zaman; G Helft; Z Fayad; V Fuster
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

Review 3.  Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data.

Authors:  Gaurav Sharma; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

4.  Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.

Authors:  E Boersma; D Poldermans; J J Bax; E W Steyerberg; I R Thomson; J D Banga; L L van De Ven; H van Urk; J R Roelandt
Journal:  JAMA       Date:  2001-04-11       Impact factor: 56.272

5.  Centrifugation speed affects light transmission aggregometry.

Authors:  M Merolla; M A Nardi; J S Berger
Journal:  Int J Lab Hematol       Date:  2011-07-27       Impact factor: 2.877

6.  Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques.

Authors:  Matthew T Rondina; Colin K Grissom; Shaohua Men; Estelle S Harris; Hansjorg Schwertz; Guy A Zimmerman; Andrew S Weyrich
Journal:  Thromb Res       Date:  2011-12-16       Impact factor: 3.944

Review 7.  Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.

Authors:  S G Chu; R C Becker; P B Berger; D L Bhatt; J W Eikelboom; B Konkle; E R Mohler; M P Reilly; J S Berger
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

8.  Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.

Authors:  S Rajagopalan; I Ford; P Bachoo; G S Hillis; B Croal; M Greaves; J Brittenden
Journal:  J Thromb Haemost       Date:  2007-07-23       Impact factor: 5.824

9.  Comparison of platelet activity measurements by use of arterial and venous blood sampling.

Authors:  B Shah; S P Sedlis; X Mai; N S Amoroso; Y Guo; J D Lorin; J S Berger
Journal:  J Thromb Haemost       Date:  2013-10       Impact factor: 5.824

10.  Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.

Authors:  Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Journal:  Chest       Date:  2007-10-01       Impact factor: 9.410

View more
  2 in total

1.  Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.

Authors:  Hua Liang; Chengxiang Yang; Bin Zhang; Hanbing Wang; Hongzhen Liu; Zhenlong Zhao; Zhiming Zhang; Xianjie Wen; Xiaohong Lai
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

Review 2.  Perioperative Management to Reduce Cardiovascular Events.

Authors:  Nathaniel R Smilowitz; Jeffrey S Berger
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.